The Carlat Child Psychiatry Report

Substance Use in Children and Adolescents (January/February/March) | 2025

View Archived Issues

Note From the Editor-in-Chief

January 1, 2025
Joshua D. Feder, MD

In our note from the Editor in Chief, Dr. Feder underlines the hope for better outcomes for the ravages of substance use disorders and a timely message for those impacted wildfires and other disasters.

Read More

A Note From The Carlat Addiction Treatment Report: Buprenorphine Prescriber Criteria

January 1, 2025
Noah Capurso, MD, MHS

Dr. Capurso, Editor-in-Chief of The Carlat Addiction Treatment Report, provides a quick guide to buprenorphine prescriber criteria.

Read More

Substance Use Treatment in Teens: What Level of Care?

January 1, 2025
Dhwani Shah, MD and Brady Heward, MD

One of the most challenging problems in adolescent care is figuring out what level of care will give patients the best chance of recovery or progress. We give you a guide to decide what level of care to recommend based on your individual patient.

Read More

Addressing the Overdose Crisis: What You Can Do

January 1, 2025
Aaron Quiggle, MD, MS

There are multiple ways that we can help our patients reduce the risk of overdose. In our interview with Dr. Aaron Quiggle, we cover screening, fentanyl testing, the use of Narcan and the importance of learning to prescribe buprenorphine.

Read More

Update on Escitalopram

January 1, 2025
Mariel Zeccola, APRN, PhD

Where does escitalopram fit in the treatment of anxiety, depression, OCD, and other disorders of children and adolescents? We review the data and help you decide where to place escitalopram in your own practice.

Read More

Vaping and Nicotine Addiction in Children and Adolescents

January 1, 2025
Jonathan P. Winickoff, MD, MPH

Nicotine is among the most addictive substances out in the community. Learn how to talk with patients and families and use the most effective strategies we know to intervene.

Read More

Dose-Dependent Mortality Risk for Second-Generation Antipsychotics in Young Adults

January 1, 2025
Susan L. Siegfreid, MD

Second generation antipsychotics (SGAs) have significant side effects, which has led us at Carlat to recommend conservative use. This research update adds to concerns about increased mortality, especially at higher doses, making conservative use of SGAs a necessity.

Read More

Guanfacine Is Effective and Safe for Children, Adolescents, and Adults

January 1, 2025
Heather Goff, MD

Guanfacine is a popular second-line treatment for ADHD in children and teens. But what happens as our patients age into adulthood? Does guanfacine remain an effective medication in adults with ADHD? This research update covers a study that tries to answer this question.

Read More

Audio Issue, Substance Use in Child and Adolescent Psychiatry, Jan/Feb/March 2025

January 1, 2025
Joshua Feder, MD
Read More

CME Post-Test, Substance Use in Children and Adolescents, CCPR, January/February/March 2025

January 1, 2025

By successfully completing the test you will be awarded a certificate for 1 CME credit.

Read More
Featured Book
Featured Video
Featured Podcast
Recommended

About

Shop Online

Newsletters

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.